betrixaban

Betrixaban: New Oral Blood Thinner Cleared by FDA

The U.S. Food and Drug Administration has granted Portola Pharmaceuticals permission to market …

Read the full story

Current News

NBCA Names Corewell Health the Inaugural NBCA Center of Excellence

The NBCA Centers of Excellence designation recognizes excellence in clinical outcomes, patient education, and post-hospitalization patient care for blood clots.…

Blood Clot Awareness Month Just Got Bigger and Brighter!

We are absolutely thrilled to reveal that the National Blood Clot Alliance has a public service announcement on the seven-story-high…